Regulation of pulmonary resistance during cardiopulmonary preservation

G. J. Kontos, K. Hashimoto, J. P. Mashburn, Hartzell V Schaff

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

To characterize the neural and vasoactive mediators of pulmonary vasoconstriction and determine whether the beneficial effect of isoproterenol could be mimicked by other agents that increase cyclic adenosine monophosphate, heart and lung organ blocks were harvested from calves and studied in a normothermic autoperfusion circuit. In the experimental protocol, measurements were obtained (A) after sternotomy but before autoperfusion (in vivo); (B) during stimulation of in vivo control with tert- butyl hydroperoxide (t-BuOOH), a lipid peroxide; (C) after cannulation and institution of in situ autoperfusion (innervated preparation); (D) following denervation and explanation (ex vivo); (E) during stimulation of ex vivo preparation with t-BuOOH; and (F,G) after administration of isoproterenol, aminophylline and prostaglandin E1 to the ex vivo preparation with (time G) and without (time F) stimulation using t-BuOOH. Plots of transpulmonary pressure gradient versus cardiac output were generated for each animal, and an index of pulmonary vascular resistance was obtained from the slope of the linear relationship. Blood samples were collected for measurement of thromboxane-B2, 6-keto-prostaglandin-F(1α), and complement activation products C3a and C5a. Pulmonary vasoconstriction occurred during in situ autoperfusion prior to denervation and increased further following denervation and ex vivo autoperfusion; vasoconstriction correlated with increased levels of circulating vasoactive mediators. The pulmonary vasoconstrictor response was greater in the denervated vascular bed compared with the innervated state. All agents reduced postexplant pulmonary vasoconstriction. We conclude that agents that increase cyclic AMP modulate the pulmonary vasoconstrictor response and thus may enhance lung preservation in the autoperfusion model as well as with other current preservation methods.

Original languageEnglish (US)
Pages (from-to)294-302
Number of pages9
JournalTransplantation
Volume53
Issue number2
StatePublished - 1992

Fingerprint

Lung
Vasoconstriction
Denervation
Vasoconstrictor Agents
Isoproterenol
Cyclic AMP
tert-Butylhydroperoxide
Aminophylline
Thromboxane B2
Sternotomy
Alprostadil
Complement Activation
Lipid Peroxides
Prostaglandins F
Catheterization
Cardiac Output
Vascular Resistance
Blood Vessels
Pressure

ASJC Scopus subject areas

  • Immunology
  • Transplantation

Cite this

Kontos, G. J., Hashimoto, K., Mashburn, J. P., & Schaff, H. V. (1992). Regulation of pulmonary resistance during cardiopulmonary preservation. Transplantation, 53(2), 294-302.

Regulation of pulmonary resistance during cardiopulmonary preservation. / Kontos, G. J.; Hashimoto, K.; Mashburn, J. P.; Schaff, Hartzell V.

In: Transplantation, Vol. 53, No. 2, 1992, p. 294-302.

Research output: Contribution to journalArticle

Kontos, GJ, Hashimoto, K, Mashburn, JP & Schaff, HV 1992, 'Regulation of pulmonary resistance during cardiopulmonary preservation', Transplantation, vol. 53, no. 2, pp. 294-302.
Kontos, G. J. ; Hashimoto, K. ; Mashburn, J. P. ; Schaff, Hartzell V. / Regulation of pulmonary resistance during cardiopulmonary preservation. In: Transplantation. 1992 ; Vol. 53, No. 2. pp. 294-302.
@article{8ddceb75e95143f5a169f5e07aaf8234,
title = "Regulation of pulmonary resistance during cardiopulmonary preservation",
abstract = "To characterize the neural and vasoactive mediators of pulmonary vasoconstriction and determine whether the beneficial effect of isoproterenol could be mimicked by other agents that increase cyclic adenosine monophosphate, heart and lung organ blocks were harvested from calves and studied in a normothermic autoperfusion circuit. In the experimental protocol, measurements were obtained (A) after sternotomy but before autoperfusion (in vivo); (B) during stimulation of in vivo control with tert- butyl hydroperoxide (t-BuOOH), a lipid peroxide; (C) after cannulation and institution of in situ autoperfusion (innervated preparation); (D) following denervation and explanation (ex vivo); (E) during stimulation of ex vivo preparation with t-BuOOH; and (F,G) after administration of isoproterenol, aminophylline and prostaglandin E1 to the ex vivo preparation with (time G) and without (time F) stimulation using t-BuOOH. Plots of transpulmonary pressure gradient versus cardiac output were generated for each animal, and an index of pulmonary vascular resistance was obtained from the slope of the linear relationship. Blood samples were collected for measurement of thromboxane-B2, 6-keto-prostaglandin-F(1α), and complement activation products C3a and C5a. Pulmonary vasoconstriction occurred during in situ autoperfusion prior to denervation and increased further following denervation and ex vivo autoperfusion; vasoconstriction correlated with increased levels of circulating vasoactive mediators. The pulmonary vasoconstrictor response was greater in the denervated vascular bed compared with the innervated state. All agents reduced postexplant pulmonary vasoconstriction. We conclude that agents that increase cyclic AMP modulate the pulmonary vasoconstrictor response and thus may enhance lung preservation in the autoperfusion model as well as with other current preservation methods.",
author = "Kontos, {G. J.} and K. Hashimoto and Mashburn, {J. P.} and Schaff, {Hartzell V}",
year = "1992",
language = "English (US)",
volume = "53",
pages = "294--302",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Regulation of pulmonary resistance during cardiopulmonary preservation

AU - Kontos, G. J.

AU - Hashimoto, K.

AU - Mashburn, J. P.

AU - Schaff, Hartzell V

PY - 1992

Y1 - 1992

N2 - To characterize the neural and vasoactive mediators of pulmonary vasoconstriction and determine whether the beneficial effect of isoproterenol could be mimicked by other agents that increase cyclic adenosine monophosphate, heart and lung organ blocks were harvested from calves and studied in a normothermic autoperfusion circuit. In the experimental protocol, measurements were obtained (A) after sternotomy but before autoperfusion (in vivo); (B) during stimulation of in vivo control with tert- butyl hydroperoxide (t-BuOOH), a lipid peroxide; (C) after cannulation and institution of in situ autoperfusion (innervated preparation); (D) following denervation and explanation (ex vivo); (E) during stimulation of ex vivo preparation with t-BuOOH; and (F,G) after administration of isoproterenol, aminophylline and prostaglandin E1 to the ex vivo preparation with (time G) and without (time F) stimulation using t-BuOOH. Plots of transpulmonary pressure gradient versus cardiac output were generated for each animal, and an index of pulmonary vascular resistance was obtained from the slope of the linear relationship. Blood samples were collected for measurement of thromboxane-B2, 6-keto-prostaglandin-F(1α), and complement activation products C3a and C5a. Pulmonary vasoconstriction occurred during in situ autoperfusion prior to denervation and increased further following denervation and ex vivo autoperfusion; vasoconstriction correlated with increased levels of circulating vasoactive mediators. The pulmonary vasoconstrictor response was greater in the denervated vascular bed compared with the innervated state. All agents reduced postexplant pulmonary vasoconstriction. We conclude that agents that increase cyclic AMP modulate the pulmonary vasoconstrictor response and thus may enhance lung preservation in the autoperfusion model as well as with other current preservation methods.

AB - To characterize the neural and vasoactive mediators of pulmonary vasoconstriction and determine whether the beneficial effect of isoproterenol could be mimicked by other agents that increase cyclic adenosine monophosphate, heart and lung organ blocks were harvested from calves and studied in a normothermic autoperfusion circuit. In the experimental protocol, measurements were obtained (A) after sternotomy but before autoperfusion (in vivo); (B) during stimulation of in vivo control with tert- butyl hydroperoxide (t-BuOOH), a lipid peroxide; (C) after cannulation and institution of in situ autoperfusion (innervated preparation); (D) following denervation and explanation (ex vivo); (E) during stimulation of ex vivo preparation with t-BuOOH; and (F,G) after administration of isoproterenol, aminophylline and prostaglandin E1 to the ex vivo preparation with (time G) and without (time F) stimulation using t-BuOOH. Plots of transpulmonary pressure gradient versus cardiac output were generated for each animal, and an index of pulmonary vascular resistance was obtained from the slope of the linear relationship. Blood samples were collected for measurement of thromboxane-B2, 6-keto-prostaglandin-F(1α), and complement activation products C3a and C5a. Pulmonary vasoconstriction occurred during in situ autoperfusion prior to denervation and increased further following denervation and ex vivo autoperfusion; vasoconstriction correlated with increased levels of circulating vasoactive mediators. The pulmonary vasoconstrictor response was greater in the denervated vascular bed compared with the innervated state. All agents reduced postexplant pulmonary vasoconstriction. We conclude that agents that increase cyclic AMP modulate the pulmonary vasoconstrictor response and thus may enhance lung preservation in the autoperfusion model as well as with other current preservation methods.

UR - http://www.scopus.com/inward/record.url?scp=0026551263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026551263&partnerID=8YFLogxK

M3 - Article

C2 - 1310822

AN - SCOPUS:0026551263

VL - 53

SP - 294

EP - 302

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 2

ER -